AIM Vaccine Co., Ltd. carries a market capitalization of 2.06B, placing it among publicly traded companies globally.
| Market Cap | 2.06B |
| Enterprise Value | N/A |
AIM Vaccine Co., Ltd.'s stock has declined approximately -55.2% over the past 52 weeks. The 50-day moving average sits at 2.19, while the 200-day moving average is 3.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | -55.2% |
| 50-Day Moving Average | 2.19 |
| 200-Day Moving Average | 3.10 |
| Average Volume (20 Days) | N/A |